The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Vishram Chawda
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter group member Sunil Vishram Chawda has filed a disclosure under SEBI SAST Regulation 29(2) regarding a change in his shareholding in Oxygenta Pharmaceutical Ltd. His holding decreased from 41,61,200 shares (11.25%) to 10,98,000 shares (2.97%), representing a sale of 30,63,200 equity shares (8.28%). The transaction was executed through an off-market share purchase agreement dated September 30, 2024, with the disclosure filed on April 24, 2025. The company's total share capital is 3,69,83,500 equity shares of Rs. 10 each. No encumbrance activity was involved in this transaction.
This is a significant promoter exit — the individual promoter's stake has dropped from 11.25% to just 2.97%, which is a negative signal for retail investors as it indicates reduced promoter confidence or a planned change in ownership. The stock may face selling pressure or volatility as the market digests the change in promoter holding.